A Comparison of Efficacy and Safety of Magnesium sulfate and Ritodrine Hydrochloride in the Management of Preterm Labor.
- Author:
Hoo Chul PARK
;
Joong Seo WANG
;
Eun Ju CHOI
;
Ji Young JEONG
;
Dong Gyu LEE
;
Jeong Seok PARK
;
Sang Dae KANG
- Publication Type:Original Article
- Keywords:
Preterm labor;
Magnesium sulfate;
Ritodrine hydrochloride
- MeSH:
Abruptio Placentae;
Calcium;
Female;
Heart Rate;
Humans;
Incidence;
Leiomyoma;
Magnesium Sulfate*;
Magnesium*;
Membranes;
Obstetric Labor, Premature*;
Placenta Previa;
Potassium;
Pre-Eclampsia;
Pregnancy;
Pregnancy, Twin;
Risk Factors;
Ritodrine*;
Rupture;
Uterine Cervical Incompetence;
Uterine Contraction;
Uterus
- From:Korean Journal of Obstetrics and Gynecology
1999;42(10):2248-2254
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: The purpose of this study was to evaluate the efficacy and safety of magnesium sulfate and ritodrine hydrochloride in the management of preterm labor. METHODS: This study was undertaken to assess the clinical efficacy & safety of magnesium sulfate and ritodrine hydrochloride on 120 patients admitted with preterm labor from Jul. 1, 1996 to Dec. 31, 1998. RESULTS: 1. The incidence of preterm labor was showed 6.0~7.7% of total number of delivery. 2. The risk factors of the preterm labor were premature rupture of membrane, severe preeclampsia, previous preterm delivery, twin pregnancy, placenta previa, fetal anomaly, incompetent cervix, placental abruption, and uterine myoma in order, but 28.6% of preterm labor had no apparent risk factors. 3. The days gained in uterus was not statistically different between the magnesium sulfate group and the ritodrine group (p<0.05) but longer in the two groups than the control group. And the delivery time was also not statistically different between the magnesium sulfate group and the ritodrine group (p<0.01) but significantly increased in the two groups than the control group. 4. The rate of complete and incomplete success was similar as 12.5% and 35% (total success rate 47.5%) in the magnesium sulfate group, 7.5% and 45% (total success rate 52.5%) in the ritodrine group but only 2.5% and 27.5% (total success rate 30%) was showed in the control group. 5. The side effects were much more in the ritodrine group than the magnesium sulfate group. The patients requiring second-line therapy were similar in the both groups but the main cause was uncontrolled uterine contraction in the magnesium sulfate group, and intolerable side effects in the ritodrine group. 6. The pulse rate was not statistically different in magnesium sulfate group but markedly increased in ritodrine group (p<0.05). After managements of preterm labor, the serum potassium and ionized calcium level was significantly decreased in the two groups (p<0.05, p<0.01). CONCLUSION: There was not significantly different efficacy and safety of magnesium sulfate and ritodrine hydrochloride in the management of preterm labor.
